The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
VIC regimen (vemurafenib/irinotecan/cetuximab) versus bevacizumab plus chemotherapy as first-line treatment for BRAFV600E-mutated advanced colorectal cancer.
 
Yijiao Chen
No Relationships to Disclose
 
Dexiang Zhu
No Relationships to Disclose
 
Ye Wei
No Relationships to Disclose
 
Jianmin Xu
No Relationships to Disclose